![]() |
The aim of this research is to identify polymorphisms in DNA which are associated with bipolar affective disorders and subsequently isolate the responsible gene(s). We have performed linkage analyses within large families and have located a susceptibility locus on chromosome 12. We are now developing a diagnostic test and attempting to isolate the causative gene(s). DEVELOPMENT OF TRANSGENIC ANIMALS AS MODELS FOR THE STUDY OF AFFECTIVE DISORDERS We have developed a line of transgenic mice with altered hypothalamic-pituitary adrenocortical (HPA) systems. This model allows for the expression of a glucocortical receptor (GR) antisense RNA in the brain. This animal model should help us to determine the neuroendocrinological mechanisms involved in affective disorders and analyze the mode of action of antidepressant drugs. ROLE OF CORTICOSTEROID RECEPTORS IN THE REGULATION OF THE HPA SYSTEM BY ANTIDEPRESSANTS Our work has also shown that different types of antidepressants can alter GR mRNA levels and increase GR gene expression in a time frame that closely follows improvements seen in clinical depression. This work brings new insights in the mode of action of antidepressant drugs and suggests a line of approach in the development of new drugs. These projects are supported by the Medical Research Council of Canada and the Fonds de la recherche en santé du Québec.
Pepin MC, Pothier F, Barden N (1992) Impaired type II glucocorticoid receptor function in mice bearing antisense RNA transgene. Nature 355: 175-178. Pepin MC, Govindan MV, Barden N (1992) Increased glucocorticoid
receptor gene promoter activity following antidepressant treatment. Barden N, Reul JMHM, Holsboer F (1995) Do antidepressants stabilize
mood through actions on the hypothalamic-pituitary-adrenocortical system? Barden N (1996) Modulation of glucocorticoid receptor gene expression by antidepressant drugs. Pharmacopsychiatry 29:12-22. Barden N, Stec I, Reul J M H M, Holsboer F (1997) Endocrine profile and neuroendocrine challenge tests in transgenic mice with impaired hypothalamic-pituitary-adrenocortical function. Neuroendocrinology 66: 212-220.
|